Thu, Sep 18, 2014, 11:47 AM EDT - U.S. Markets close in 4 hrs 13 mins


% | $
Quotes you view appear here for quick access.

Valeant Pharmaceuticals International, Inc. Message Board

  • gerthagertha gerthagertha Dec 7, 2012 3:52 PM Flag

    VRX overvalued & has the rank 8.1...


    Over at Extreme Value Stocks fair-value is at 33.22

    This topic is deleted.
    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Gertha, EVS, is a rear-view looking mechanism, and as such, presents a small window for evaluating a stock.

      For the forward looking investor that is; 5+ years, VRX is quite intriguing. I have a position in VRX, and a larger position in AGN -- the 800 LB gorilla -- leader in this sector.
      Allergan will be a big winner and represents the superior play; however, VRX will be a big winner too, by it's mere presence, size and offerings.
      There is room for VRX and other players in this sector.
      This is a win-win for both; AGN and VRX, in growing and expanding the depth and breadth of the aesthetic and dermatology markets.
      Competition doesn't have to be a win-lose proposition folks...
      This will be a huge upside for the BIG Players when they both flex their competitive marketing prowess; and it will be immediate!
      For the cognoscenti investor, this is like "double-barrel-pin-action" for the foreseeable future.

    • Who can anyone take a name like GerthaGertha, seriously..LOL Undervalued is more like it!!

      Sentiment: Strong Buy

121.3401-0.5099(-0.42%)11:47 AMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.